Andrew S. Davis - 01 Dec 2022 Form 4 Insider Report for Silk Road Medical Inc

Role: Chief Commercial Officer
Signature: /s/Mhairi Jones, by power of attorney
Issuer symbol: N/A
Transactions as of: 01 Dec 2022
Net transactions value: -$347,452
Form type: 4
Filing time: 02 Dec 2022, 17:40:55 UTC
Previous filing: 01 Nov 2022
Next filing: 04 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SILK	Common Stock	Options Exercise	$3,630	+2,486	+2.5%	$1.46^*	100,691	01 Dec 2022	Direct	F1
transaction	SILK	Common Stock	Sale	$131,758	-2,486	-2.5%	$53.00	98,205	01 Dec 2022	Direct	F1
transaction	SILK	Common Stock	Options Exercise	$6,827	+4,267	+4.3%	$1.60^*	102,472	01 Dec 2022	Direct	F1
transaction	SILK	Common Stock	Sale	$226,151	-4,267	-4.2%	$53.00	98,205	01 Dec 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SILK	Option (right to buy)	Options Exercise	$0	-2,486	-100%	$0.000000^*	0	01 Dec 2022	Common Stock	2,486	$1.46	Direct	F1, F2
transaction	SILK	Option (right to buy)	Options Exercise	$0	-4,267	-14%	$0.000000	27,208	01 Dec 2022	Common Stock	4,267	$1.60	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on May 20, 2022.
F2	All of the shares subject to this option are fully vested and exercisable as of the date hereof.